Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 925 of 1631 entries
View as:

A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT05656911 Org: User:
Start: 12/21/22 End: 01/31/24 Due: 01/31/25

An Observational Study, Called DEAR, to Learn More About Treatment With Darolutamide, Enzalutamide and Apalutamide in Men With Non-metastatic Castration-resistant Prostate Cancer in Real World Settings

Phase: N/A Priority: Normal
NCT ID: NCT05362149 Org: User:
Start: 04/04/22 End: 06/30/23 Due: 06/30/24

Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00044538 Org: User:
Start: 12/31/01 End: 06/30/04 Due: 06/30/05

Mirena Post-marketing Surveillance in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01414140 Org: User:
Start: 05/31/07 End: 10/31/12 Due: 10/31/13

FR01 and FR20 IUS (Intrauterine System) Wearing Study

Phase: N/A Priority: Normal
NCT ID: NCT01595022 Org: User:
Start: 01/31/10 End: 09/30/10 Due: 09/30/11

Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC

Phase: N/A Priority: Normal
NCT ID: NCT03347292 Org: User:
Start: 06/18/18 End: 09/06/22 Due: 09/06/23

Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)

Phase: N/A Priority: Normal
NCT ID: NCT00185198 Org: User:
Start: 09/30/04 End: 10/31/07 Due: 10/31/08

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Phase: N/A Priority: Normal
NCT ID: NCT02687867 Org: User:
Start: 02/12/16 End: 03/01/16 Due: 03/01/17

Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin

Phase: N/A Priority: Normal
NCT ID: NCT00329628 Org: User:
Start: 02/28/06 End: 03/31/07 Due: 03/31/08

Evaluate Onset of Action of a Fast Release Aspirin

Phase: N/A Priority: Normal
NCT ID: NCT01420094 Org: User:
Start: 06/16/11 End: 09/08/11 Due: 09/08/12

Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body

Phase: N/A Priority: Normal
NCT ID: NCT04281147 Org: User:
Start: 02/24/20 End: 06/22/21 Due: 06/22/22

Study to Learn More About the Physical Activity Level of Patients Suffering From Hemophilia A Treated With Damoctocog Alfa Pegol (LIFE ACTIVE Study)

Phase: N/A Priority: Normal
NCT ID: NCT04091386 Org: User:
Start: 06/10/21 End: 07/05/24 Due: 07/05/25

A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide

Phase: N/A Priority: Normal
NCT ID: NCT05526248 Org: User:
Start: 12/19/22 End: 12/04/24 Due: 12/04/25

Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy

Phase: N/A Priority: Normal
NCT ID: NCT01939223 Org: User:
Start: 12/02/13 End: 08/29/16 Due: 08/29/17

A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

Phase: N/A Priority: Normal
NCT ID: NCT05686070 Org: User:
Start: 01/26/23 End: 10/20/25 Due: 10/20/26

Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay

Phase: N/A Priority: Normal
NCT ID: NCT02872233 Org: User:
Start: 05/26/15 End: 06/10/15 Due: 06/10/16

Aerosolized Randomized Iloprost Study II (AIR - II) Long-Term Safety, Tolerability, and Clinical Effects of Iloprost Inhalation in Patients With Primary or Secondary Pulmonary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00414687 Org: User:
Start: 07/31/98 End: 05/31/01 Due: 05/31/02

A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT02452515 Org: User:
Start: 07/31/15 End: 03/31/16 Due: 03/31/17

Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications.

Phase: N/A Priority: Normal
NCT ID: NCT04218266 Org: User:
Start: 01/30/20 End: 10/08/21 Due: 10/08/22

European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)

Phase: N/A Priority: Normal
NCT ID: NCT01260870 Org: User:
Start: 08/15/11 End: 07/15/13 Due: 07/15/14

A Study to Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults

Phase: N/A Priority: Normal
NCT ID: NCT04999202 Org: User:
Start: 08/30/21 End: 01/20/25 Due: 01/20/26

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT01439152 Org: User:
Start: 09/07/11 End: 07/30/19 Due: 07/30/20

Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01397955 Org: User:
Start: 01/31/09 End: 04/30/14 Due: 04/30/15

Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients

Phase: N/A Priority: Normal
NCT ID: NCT02246686 Org: User:
Start: 11/30/14 End: 04/30/16 Due: 04/30/17

Special Drug Use Investigation of EYLEA for Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT02425501 Org: User:
Start: 01/20/15 End: 08/13/19 Due: 08/13/20